Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study

BACKGROUND/AIMS: The short- and long-term effects of adalimumab (ADA) on Korean patients with intestinal Behcet’s disease (BD) for remain unclear. Therefore, a multicenter study was performed to evaluate the efficacy and safety of ADA in Korean patients with intestinal BD in a real-world setting. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Bum, Hong, Hee Seung, Lee, Chang Kyun, Lee, Bo-In, Kim, Sol, Koh, Seong-Joon, Yu, Hosun, Park, Jung-Bin, Hwang, Sung Wook, Ye, Byong Duk, Yang, Suk-Kyun, Park, Sang Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493451/
https://www.ncbi.nlm.nih.gov/pubmed/37491721
http://dx.doi.org/10.3904/kjim.2022.394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493451/
https://www.ncbi.nlm.nih.gov/pubmed/37491721
http://dx.doi.org/10.3904/kjim.2022.394

Ejemplares similares